Leidos Holdings, Inc. (NYSE:LDOS) Shares Sold by Meeder Asset Management Inc.

Meeder Asset Management Inc. lessened its position in shares of Leidos Holdings, Inc. (NYSE:LDOS) by 88.1% in the 3rd quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor owned 8,918 shares of the aerospace company’s stock after selling 65,811 shares during the period. Meeder Asset Management Inc.’s holdings in Leidos were worth $1,454,000 as of its most recent SEC filing.

Other large investors also recently modified their holdings of the company. Allspring Global Investments Holdings LLC raised its position in shares of Leidos by 51.2% during the 3rd quarter. Allspring Global Investments Holdings LLC now owns 837,370 shares of the aerospace company’s stock worth $136,491,000 after acquiring an additional 283,558 shares in the last quarter. Atria Investments Inc raised its holdings in Leidos by 100.1% during the third quarter. Atria Investments Inc now owns 8,837 shares of the aerospace company’s stock worth $1,440,000 after purchasing an additional 4,421 shares in the last quarter. Los Angeles Capital Management LLC lifted its position in shares of Leidos by 21.4% during the 3rd quarter. Los Angeles Capital Management LLC now owns 55,165 shares of the aerospace company’s stock worth $8,992,000 after buying an additional 9,710 shares during the last quarter. Point72 Asia Singapore Pte. Ltd. boosted its holdings in shares of Leidos by 188.2% in the 2nd quarter. Point72 Asia Singapore Pte. Ltd. now owns 8,274 shares of the aerospace company’s stock valued at $1,207,000 after buying an additional 5,403 shares in the last quarter. Finally, Advisors Asset Management Inc. grew its position in shares of Leidos by 97.2% in the 1st quarter. Advisors Asset Management Inc. now owns 12,904 shares of the aerospace company’s stock valued at $1,692,000 after buying an additional 6,360 shares during the last quarter. 76.12% of the stock is owned by hedge funds and other institutional investors.

Wall Street Analyst Weigh In

LDOS has been the subject of several research analyst reports. Barclays upped their price objective on shares of Leidos from $165.00 to $210.00 and gave the company an “overweight” rating in a research note on Monday, November 4th. The Goldman Sachs Group lifted their price target on Leidos from $205.00 to $228.00 and gave the stock a “buy” rating in a research report on Wednesday, October 30th. Royal Bank of Canada increased their price objective on Leidos from $145.00 to $180.00 and gave the company a “sector perform” rating in a report on Wednesday, October 30th. Bank of America lifted their target price on shares of Leidos from $160.00 to $165.00 and gave the company a “buy” rating in a report on Wednesday, August 7th. Finally, TD Cowen increased their price target on shares of Leidos from $175.00 to $200.00 and gave the stock a “buy” rating in a research note on Wednesday, October 30th. Two analysts have rated the stock with a hold rating, eleven have given a buy rating and one has issued a strong buy rating to the company. Based on data from MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and an average target price of $191.23.

Insiders Place Their Bets

In other Leidos news, Director Surya N. Mohapatra sold 2,748 shares of the company’s stock in a transaction dated Thursday, November 7th. The shares were sold at an average price of $194.97, for a total value of $535,777.56. Following the sale, the director now owns 20,001 shares of the company’s stock, valued at $3,899,594.97. This represents a 12.08 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Also, Director Robert C. Kovarik, Jr. sold 1,047 shares of the firm’s stock in a transaction that occurred on Thursday, October 31st. The stock was sold at an average price of $184.94, for a total transaction of $193,632.18. Following the transaction, the director now directly owns 6,408 shares of the company’s stock, valued at approximately $1,185,095.52. This trade represents a 14.04 % decrease in their ownership of the stock. The disclosure for this sale can be found here. 0.96% of the stock is owned by company insiders.

Leidos Trading Down 0.4 %

Shares of LDOS stock opened at $158.28 on Wednesday. Leidos Holdings, Inc. has a 1-year low of $104.72 and a 1-year high of $202.90. The company has a debt-to-equity ratio of 0.87, a current ratio of 1.23 and a quick ratio of 1.15. The business’s fifty day moving average price is $169.66 and its 200 day moving average price is $155.76. The firm has a market capitalization of $21.12 billion, a PE ratio of 18.03, a P/E/G ratio of 1.08 and a beta of 0.68.

Leidos (NYSE:LDOS) last announced its quarterly earnings results on Tuesday, October 29th. The aerospace company reported $2.93 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.96 by $0.97. Leidos had a net margin of 7.37% and a return on equity of 30.31%. The business had revenue of $4.19 billion during the quarter, compared to the consensus estimate of $4.06 billion. During the same quarter last year, the firm posted $2.03 EPS. The business’s revenue was up 6.9% compared to the same quarter last year. As a group, sell-side analysts forecast that Leidos Holdings, Inc. will post 10.07 EPS for the current fiscal year.

Leidos Increases Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Tuesday, December 31st. Investors of record on Monday, December 16th will be paid a $0.40 dividend. This is an increase from Leidos’s previous quarterly dividend of $0.38. This represents a $1.60 annualized dividend and a yield of 1.01%. The ex-dividend date of this dividend is Monday, December 16th. Leidos’s dividend payout ratio (DPR) is presently 17.31%.

Leidos Profile

Leidos Holdings, Inc, together with its subsidiaries, provides services and solutions in the defense, intelligence, civil, and health markets in the United States and internationally. The company operates through Defense Solutions, Civil, and Health segments. The Defense Solutions segment offers national security solutions and systems for air, land, sea, space, and cyberspace for the U.S.